Critics Blast FDA Plan For RADARS Drug Misuse Surveillance Program
The Research, Abuse, Diversion, and Addiction-Related Surveillance system was an in-house system at Purdue Pharma and later sold to the Denver Health and Hospital Authority. Advocacy groups are pushing back against the FDA's use of RADARS over its ties to the pharma industry.
Source: kffhealthnews.org